Afya Limited - AFYA STOCK NEWS

Afya reported strong financial results for Q3 2024, with net revenue increasing 16.3% YoY to R$841.2 million. The company's Adjusted EBITDA grew 25.0% YoY to R$347.9 million, with margin expansion of 290 bps to 41.4%. Net Income rose 26.4% YoY to R$124.1 million. For the nine-month period, net revenue increased 14.4% to R$2,455.3 million, while Adjusted EBITDA grew 24.3% to R$1,089.6 million. The company completed the acquisition of Unidom, adding 300 medical seats, and received authorization for 80 additional seats at UNIMA and 10 seats at Unigranrio, bringing total approved seats to 3,593.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced it will release its third-quarter and nine months 2024 financial results on November 13th, 2024, after market close. The company will host a conference call and webcast at 05:00 pm EST to discuss the results. Investors can access the webcast through Afya's Investor Relations website and participate via various dial-in numbers provided for Brazil and United States.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced its upcoming Afya Day 2024 event. Scheduled for October 29th, 2024, the event will be held in a hybrid format, allowing both in-person and online participation.

The event will feature presentations from Afya's executive team, covering the company's growth, business strategy, and future outlook. It will take place from 9:00 a.m. to 12:00 p.m. (São Paulo time) and 8:00 a.m. to 11:00 a.m. (EST).

In-person attendees can join at Afya's São Paulo Flagship location. Due to in-person capacity, early registration is encouraged. Interested participants can register for the event through the provided link on Afya's investor relations website.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group and medical practice solutions provider, has announced a commitment to provide 5 million free health consultations by 2030. This initiative aligns with Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all.

To achieve this goal, Afya plans to expand its network of outpatient clinics from 20 to 27, offering various medical specialties including psychology, physiotherapy, and dentistry. Additionally, the company will incorporate 16 undergraduate units into the Afya Digital Health Network, a telemedicine project facilitating knowledge exchange among professors, students, and preceptors.

Virgilio Gibbon, Afya's CEO and SDG 3 Impact Leader, emphasized the company's commitment to aligning business objectives with meaningful purpose, generating lasting impact on served populations, and promoting long-term improvements in community health and quality of life.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education group, has announced a positive outcome from the Ministry of Education (MEC) regarding Universidade do Grande Rio Professor José de Souza Herdy (Unigranrio). The MEC has granted Unigranrio's request for reconsideration, resulting in the reestablishment of 10 medical seats in Rio de Janeiro. This decision brings Unigranrio's total medical seats to 318 across both campuses. Consequently, Afya's total approved medical seats have increased to 3,593. This development underscores Afya's commitment to excellence in medical education and reinforces its position as a leading medical education provider in Brazil.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education and practice solutions provider, has received the full R$500 million disbursement from the International Finance (IFC). This loan, IFC's first sustainability-linked loan in the education sector based on social targets, will support Afya's expansion program. The loan's pricing is tied to Afya's performance in social key performance indicators, including free medical consultations and education quality metrics.

The loan terms include repayment in seven semi-annual installments starting April 2027, with an interest rate of Brazilian CDI plus 1.2%. Notably, the rate may be reduced by 15 basis points if Afya achieves the specified sustainability KPIs, incentivizing the company's commitment to social impact alongside its business growth.

Afya (Nasdaq: AFYA; B3: A2FY34) has announced its financial results for Q2 and the first half of 2024. Notable highlights include:

For Q2 2024:

• Net Revenue increased by 13.7% YoY to R$809.9 million.
• Adjusted EBITDA grew by 28.2% YoY to R$343.8 million, with a margin of 42.5%, up 490 bps YoY.
• Net Income surged 85.3% YoY to R$162.2 million; Adjusted Net Income rose by 59.5% YoY to R$210.3 million, with Adjusted EPS up 61.8%.

In H1 2024:

• Net Revenue increased by 13.5% YoY to R$1,614.1 million.
• Adjusted EBITDA grew by 23.9% YoY to R$741.7 million, with a margin of 45.9%, up 380 bps YoY.
• Net Income increased by 80.5% YoY to R$370.5 million; Adjusted Net Income rose by 54.7% YoY to R$461.3 million, with Adjusted EPS up 56.9%.

Afya has approved 80 additional seats at UNIMA Alagoas and closed the acquisition of Unidom, adding 300 seats. The company's ecosystem now includes ~320,000 users.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education and practice solutions provider, has secured a sustainability-linked loan of up to R$500 million from the International Finance (IFC). This financing, IFC's first in the education sector tied to social targets, will support Afya's expansion through acquisitions.

The loan's pricing is linked to Afya achieving specific social key performance indicators, including free medical consultations for the community and education quality metrics. The loan terms include:

• Repayment in 7 semi-annual installments starting April 2027
• Interest rate: Brazilian CDI rate plus 1.2%
• Potential 15 bps rate reduction if sustainability targets are met

This strategic move underscores Afya's commitment to sustainable growth and social impact in Brazil's healthcare education sector.

Afya (Nasdaq: AFYA; B3: A2FY34), Brazil's leading medical education and practice solutions provider, has released its 2023 Sustainability Report. The report adheres to Global Reporting Initiative (GRI) standards and aligns with the Sustainable Development Goals (SDGs). It also incorporates indicators from the Sustainability Accounting Standards Board (SASB) and elements from the International Integrated Reporting Council (IIRC).

The report includes results from Afya's fourth Greenhouse Gas (GHG) Emissions Inventory. Both the sustainability report and the GHG inventory have been independently audited by KPMG. This comprehensive document showcases Afya's sustainability journey throughout 2023, emphasizing its commitment to transparent and responsible business practices in the medical education sector.